Attached files
| file | filename |
|---|---|
| EX-32.1 - EX-32.1 - ENANTA PHARMACEUTICALS INC | d245582dex321.htm |
| EX-31.2 - EX-31.2 - ENANTA PHARMACEUTICALS INC | d245582dex312.htm |
| EX-31.1 - EX-31.1 - ENANTA PHARMACEUTICALS INC | d245582dex311.htm |
| EX-21.1 - EX-21.1 - ENANTA PHARMACEUTICALS INC | d245582dex211.htm |
| 10-K - FORM 10-K - ENANTA PHARMACEUTICALS INC | d245582d10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-189217, 333-192935, 333-202257 and No. 333-209542) of Enanta Pharmaceuticals, Inc. of our report dated December 9, 2016 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
December 9, 2016